paxilline has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belyaeva, EA; Sokolova, TV | 1 |
| Houtepen, F; Huigsloot, M; Tijdens, IB; van de Water, B | 1 |
2 other study(ies) available for paxilline and Necrosis
| Article | Year |
|---|---|
Mitigating effect of paxilline against injury produced by Cd
Topics: Animals; Apoptosis; Cadmium; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Environmental Pollutants; Indoles; Membrane Potential, Mitochondrial; Mitochondria, Liver; Necrosis; PC12 Cells; Potassium Channel Blockers; Rats; Reactive Oxygen Species | 2020 |
Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Division; Cell Survival; Cisplatin; Cross-Linking Reagents; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Focal Adhesion Protein-Tyrosine Kinases; Gene Deletion; Genes, Dominant; Green Fluorescent Proteins; LLC-PK1 Cells; Luminescent Proteins; Microscopy, Fluorescence; Necrosis; Paxillin; Phosphoproteins; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Signal Transduction; Swine; Time Factors; Transfection | 2001 |